David O'Connell has extensive work experience in the pharmaceutical industry. David began their career at Aptuit as a Supervisory Scientist from October 2002 to October 2009. Following that, they joined Penn Pharma, a PCI company, where they served as the Head of Formulation Development from October 2009 to October 2015. Currently, they work at PCI Pharma Services as the Director of Pharmaceutical Development since October 2015, and they also hold the position of Director of Scientific Affairs from September 2017.
David O'Connell pursued their education at Glasgow Caledonian University from 1998 to 2002. During this period, they completed their Bachelor of Science degree in Applied Bioscience, specializing in Microbiology.
September, 2017 - present
October, 2015
Executive Director of Scientific Affairs at TMRW Life Sciences
Director of Scientific Affairs at Turner Syndrome Foundation
Associate Director of Scientific Affairs at Accellix
Director Of Scientific Affairs, Carnosyn(r) Brands at Natural Alternatives International
Senior Director Of Scientific Affairs at Hematogenix